Skip to main content
Signal8

VSEE HEALTH, INC. (VSEE) Form 424B3 — May 29, 2026

$VSEEForm 424B3Filed May 29, 2026, 1:52 PM ET0001185185-26-002174Original filing

VSee Health filed a prospectus supplement to update information for the resale of up to 33.8 million shares by selling stockholders, including Manatt, Phelps & Phillips and Armistice. This filing signals significant potential selling pressure on the market, as these shares are registered for public resale. The attached 10-Q for the quarter ended March 31, 2026, reveals severe financial distress. The company reported a net loss of $2.6 million and an accumulated deficit of $85 million, with cash reserves of only $1.3 million against total liabilities of $12.7 million.

Key figures

Revenue
3160185
Total Debt
12695349
Cash Position
1346132
Shares Outstanding
48599421
Total equity
6321070
Last stock price
0.182
Shares for resale
33808195
Total liabilities
12695349

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.